| Literature DB >> 25500367 |
Elisa Montaldo1, Luiz Gustavo Teixeira-Alves2, Timor Glatzer2, Pawel Durek3, Ulrik Stervbo3, Wiebke Hamann2, Marina Babic4, Daniela Paclik2, Katharina Stölzel5, Jörn Gröne6, Laura Lozza7, Kerstin Juelke8, Nadine Matzmohr9, Fabrizio Loiacono10, Francesca Petronelli10, Nicholas David Huntington11, Lorenzo Moretta10, Maria Cristina Mingari1, Chiara Romagnani12.
Abstract
Group 3 innate lymphoid cells (ILC3s) are defined by the expression of the transcription factor RORγt, which is selectively required for their development. The lineage-specified progenitors of ILC3s and their site of development after birth remain undefined. Here we identified a population of human CD34(+) hematopoietic progenitor cells (HPCs) that express RORγt and share a distinct transcriptional signature with ILC3s. RORγt(+)CD34(+) HPCs were located in tonsils and intestinal lamina propria (LP) and selectively differentiated toward ILC3s. In contrast, RORγt(-)CD34(+) HPCs could differentiate to become either ILC3s or natural killer (NK) cells, with differentiation toward ILC3 lineage determined by stem cell factor (SCF) and aryl hydrocarbon receptor (AhR) signaling. Thus, we demonstrate that in humans RORγt(+)CD34(+) cells are lineage-specified progenitors of IL-22(+) ILC3s and propose that tonsils and intestinal LP, which are enriched both in committed precursors and mature ILC3s, might represent preferential sites of ILC3 lineage differentiation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25500367 DOI: 10.1016/j.immuni.2014.11.010
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745